✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals
Market Cap
₹3,326 Cr.
P/E
25.02
  • Advanced Enzyme
  • Fermenta Biotech
  • Concord Biotech
  • TJI Pharma
FAQs on Advanced Enzyme Technologies Ltd. Shareprice

Advanced Enzyme has given lower returns compared to its competitors.
Advanced Enzyme has grown at ~-23.13% over the last 1yrs while peers have grown at a median rate of 19.83%

Advanced Enzyme is not expensive.
Latest PE of Advanced Enzyme is 25.02, while 3 year average PE is 29.94.
Also latest EV/EBITDA of Advanced Enzyme is 15.87 while 3yr average is 18.79.

Growth Table
  • Advanced Enzyme Technologies Ltd.
  • Fermenta Biotech
  • Concord Biotech
Balance Sheet
  • Advanced Enzyme Technologies Ltd.
  • Fermenta Biotech
  • Concord Biotech
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Advanced Enzyme Technologies Ltd.
  • Fermenta Biotech
  • Concord Biotech
Cash Flow
  • Advanced Enzyme Technologies Ltd.
  • Fermenta Biotech
  • Concord Biotech
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Advanced Enzyme Technologies Ltd.
  • Fermenta Biotech
  • Concord Biotech
Quarterly Results
  • Advanced Enzyme Technologies Ltd.
  • Fermenta Biotech
  • Concord Biotech
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
FAQs on Advanced Enzyme Technologies Ltd. Financials

Balance sheet of Advanced Enzyme is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of Advanced Enzyme is increasing.
Latest debt of Advanced Enzyme is -₹85.58 Crs as of Sep-24.
This is greater than Mar-24 when it was -₹261.29 Crs.

Yes, profit is increasing.
The profit of Advanced Enzyme is ₹137 Crs for TTM, ₹133 Crs for Mar 2024 and ₹106 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Advanced Enzyme latest dividend payout ratio is 42.78% and 3yr average dividend payout ratio is 20.91%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech